Pseudoproline dipeptide resource center
>>	Novabiochem resources for pseudoproline dipeptides
	Synthesis of wild-type and phosphorylated phospholamban New!
	Smart peptide synthesis: Synthesis of the Rantes New!
	Smart peptide synthesis: Synthesis of PADRE-Muc chimeric peptide New!
	Synthesis of neurotoxic prion peptide (106 - 126) New!
	Synthesis of thymosin-α1 using pseudoproline dipeptides
	Expediting convergent synthesis with pseudoproline dipeptides
	Synthesis of highly amyloidogenic human IAPP using pseudoproline dipeptides
	Derivatives for the synthesis of difficult sequences
	Synthesis of long peptides using pseudoproline dipeptides
	Stepwise solid phase synthesis of a 120 residue peptide related to FAS death domain
	Expediting the Fmoc solid phase synthesis of long peptides through the application of dimethyloxazolidine dipeptides
	Guidelines for the use of pseudoproline dipeptides
	Synthesis design using pseudoproline dipeptides
	Exploring strategies for peptide synthesis
	Epimerization-free fragment condensation with pseudoproline (oxazolidine) dipeptides
>>	Application examples
	Long peptides
	Phosphopeptides
	Fragment condensation
	Impossible peptides
>>	Literature citing use of pseudoproline dipeptides
	An appraisal of the effectiveness of oxazolidine dipeptides in preventing aggregation during Fmoc solid phase synthesis of difficult peptides
	The synthesis of difficult peptides using 2-hydroxy-4-methoxybenzyl (Hmb) or pseudoproline amino acid building blocks: a comparative study
	Access to the inaccessible sequence of Cpn 60.1 (195-217) by the temporary oxazolidine protection of selected amide bonds
	Semisynthesis and characterization of the first analogues of Pro-neuropeptide Y
	Expediting the Fmoc solid phase synthesis of long peptides through the application of dimethyloxazolidine dipeptides
	Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly aggregation prone polypeptide New!
	Pseudoprolines as removable turn inducers: tools for the cyclization of small peptides New!
	Overcoming challenges in automated long peptide synthesis - a multi-pronged approach New!

 

Change Country | Contact Us | Privacy Policy | Terms and Conditions   ©2009 Calbiochem, Novabiochem, & Novagen are brands of EMD Chemicals Inc., an Affiliate of Merck KGaA, Darmstadt, Germany.